Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 30, 2021 09:04 ET | Source: OPKO Health, Inc.

OPKO Health to Participate in Two Upcoming Investment Conferences

MIAMI, Aug. 30, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in two upcoming virtual investor conferences. 14th Annual Barrington...
July 29, 2021 16:05 ET | Source: OPKO Health, Inc.

OPKO Health Reports 2021 Second Quarter Business Highlights and Financial Results

MIAMI, July 29, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended June 30, 2021. Business Highlights ...
July 20, 2021 08:00 ET | Source: OPKO Health, Inc.

OPKO Health to Report Second Quarter 2021 Financial Results on July 29, 2021

MIAMI, July 20, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended June 30, 2021, as well as discuss financial...
July 12, 2021 08:00 ET | Source: OPKO Health, Inc.

OPKO Health Licenses Oligonucleotide Therapeutics Platform to CAMP4 Therapeutics

MIAMI, July 12, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced it has entered into an exclusive worldwide agreement with privately held CAMP4 Therapeutics Corporation...
July 08, 2021 16:05 ET | Source: OPKO Health, Inc.

OPKO Health to Present at the Ladenburg Thalmann Healthcare Conference

MIAMI, July 08, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the Ladenburg Thalmann Healthcare Conference being held virtually...
June 22, 2021 08:00 ET | Source: OPKO Health, Inc.

OPKO Health Appoints Katherine Stueland as President and CEO of GeneDx

MIAMI, June 22, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced the appointment of Katherine Stueland as President and Chief Executive Officer of GeneDx, Inc., the global...
June 21, 2021 08:03 ET | Source: OPKO Health, Inc.

OPKO Health to Develop and Commercialize RAYALDEE® in Greater China with Nicoya Therapeutics

MIAMI, June 21, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its subsidiary EirGen Pharma has entered into an agreement with Nicoya Macau Limited, an affiliate of...
June 17, 2021 07:00 ET | Source: OPKO Health, Inc.

OPKO Health Announces Sale of its Sterile Fill and Finish Manufacturing Facility in Ireland

MIAMI, June 17, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces that its subsidiary, EirGen Pharma, Ltd., has entered into a definitive agreement to sell one of its facilities in...
May 27, 2021 08:30 ET | Source: OPKO Health, Inc.

OPKO Health to Participate in the Jefferies Virtual Healthcare Conference

MIAMI, May 27, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announced today that management will be participating in the Jefferies Virtual Healthcare Conference being held June 1-4,...
May 24, 2021 07:30 ET | Source: OPKO Health, Inc.

OPKO Health Reports Transfer of Licensed Rights to RAYALDEE® in Japan to Vifor

MIAMI, May 24, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced a transfer of the licensed rights to RAYALDEE® in Japan from Japan Tobacco Inc. (JT) to Vifor Fresenius...